Aizon Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 120

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $20M

  • Investors
  • 13

Aizon General Information

Description

Developer of a data analytics and AI platform designed to improve pharma manufacturing processes. The company's platform offers acquisition, recording, visualization, and analysis of manufacturing data for the optimization of industrial processes in a simple, regulated, and traceable way, enabling pharma and other clients to discover new ways to optimize processes, reduce manufacturing quality issues, and enhance regulatory compliance.

Contact Information

Website
www.aizon.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 44 Montgomery Street
  • 3rd Floor
  • San Francisco, CA 94104
  • United States
+1 (628) 000-0000
Primary Industry
Enterprise Systems (Healthcare)
Vertical(s)
Advanced Manufacturing, Big Data, SaaS, Artificial Intelligence & Machine Learning, TMT
Corporate Office
  • 44 Montgomery Street
  • 3rd Floor
  • San Francisco, CA 94104
  • United States
+1 (628) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aizon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 08-Feb-2024 $20M 000.00 0000 Completed Generating Revenue
4. Later Stage VC (Series B) 01-Jan-2001 000.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 02-Mar-2020 0000 000.00 0000 Completed Generating Revenue
2. Later Stage VC 01-Oct-2019 $8.5M $8.62M 000.00 Completed Generating Revenue
1. Accelerator/Incubator 27-Jan-2016 $125K $125K Completed Generating Revenue
To view Aizon’s complete valuation and funding history, request access »

Aizon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B-2 0,000,000 00.000000 00 00.0 00.0 00 00.00 0.000
Series B-1 0,000,000 00.000000 00 00.00 00.00 00 00.0 0.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 3 000,000 00.000000 00 00.0 00.0 00 00.00 0.000
Seed 2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 1 315,790 $0.000010 8% $0.4 $0.4 1x $0.4 0.42%
Seed 2,063,154 $0.000010 8% $2.38 $2.38 1x $1.51 4.36%
To view Aizon’s complete cap table history, request access »

Aizon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a data analytics and AI platform designed to improve pharma manufacturing processes. The company's platform
Enterprise Systems (Healthcare)
San Francisco, CA
120 As of 2024
000.00
0000 0000-00-00
00000000000 000.00

000000

llum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
0000000000 0000000 (
San Francisco, CA
0000 As of 0000
00000
0000000000 0 00000

000000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000000000 0000000 (
Richardson, TX
000 As of 0000
000.00
00000 0000-00-00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aizon Competitors (62)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Innovaccer Venture Capital-Backed San Francisco, CA 0000 00000 0000000000 0 00000
MedeAnalytics Private Equity-Backed Richardson, TX 000 000.00 000000000000 000.00
HealthVerity Venture Capital-Backed Philadelphia, PA 000 00000 00000000000 00000
Hindsait Venture Capital-Backed Hackensack, NJ 0 000000000000
Prognos Health Venture Capital-Backed New York, NY 00 000.00 0000 000.00
You’re viewing 5 of 62 competitors. Get the full list »

Aizon Patents

Aizon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11544656-B1 Self qualified process for cloud based applications Active 31-Dec-2019 000000000000 00
US-10901962-B2 Managing data for regulated environments Active 06-Feb-2015 0000000000 00
US-20160267150-A1 Managing data for regulated environments Active 06-Feb-2015 0000000000 0
US-20210141786-A1 Managing data for regulated environments Active 06-Feb-2015 0000000000 0
US-12061618-B2 Managing data for regulated environments Active 06-Feb-2015 G06F16/248 00
To view Aizon’s complete patent history, request access »

Aizon Executive Team (12)

Name Title Board Seat
Josep Gubau Co-Founder, Chief Executive Officer, Chief Technology Officer & Chairman
David Merino Chief Operating Officer & Chief Financial Officer
Claus Abildgren Chief Revenue Officer & Alliances & Marketing Executive
Toni Manzano Ph.D Co-Founder, Chief Science Officer & Board Member
Andy Alasso CPO, Customer Success Executive & Senior Vice President of Product Management
You’re viewing 5 of 12 executive team members. Get the full list »

Aizon Board Members (7)

Name Representing Role Since
Andrew McLoughlin Uncork Capital Board Member 000 0000
Josep Gubau Aizon Co-Founder, Chief Executive Officer, Chief Technology Officer & Chairman 000 0000
Pere Merino Self Co-Founder & Board Member 000 0000
Scott B. Waldman Self Board Member 000 0000
Toni Manzano Ph.D Aizon Co-Founder, Chief Science Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Aizon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aizon Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
NewVale Capital Growth/Expansion Minority 000 0000 000000 0
Institut Català de Finances Venture Capital Minority 000 0000 000000 0
Atlantic Bridge Capital Growth/Expansion Minority 000 0000 000000 0
Cantos Ventures Venture Capital Minority 000 0000 000000 0
Crosslink Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Aizon FAQs

  • When was Aizon founded?

    Aizon was founded in 2013.

  • Who is the founder of Aizon?

    Josep Gubau, Toni Manzano Ph.D, and Pere Merino are the founders of Aizon.

  • Who is the CEO of Aizon?

    Josep Gubau is the CEO of Aizon.

  • Where is Aizon headquartered?

    Aizon is headquartered in San Francisco, CA.

  • What is the size of Aizon?

    Aizon has 120 total employees.

  • What industry is Aizon in?

    Aizon’s primary industry is Enterprise Systems (Healthcare).

  • Is Aizon a private or public company?

    Aizon is a Private company.

  • What is the current valuation of Aizon?

    The current valuation of Aizon is 0000.

  • What is Aizon’s current revenue?

    The current revenue for Aizon is 00000.

  • How much funding has Aizon raised over time?

    Aizon has raised $61.1M.

  • Who are Aizon’s investors?

    NewVale Capital, Institut Català de Finances, Atlantic Bridge Capital, Cantos Ventures, and Crosslink Capital are 5 of 13 investors who have invested in Aizon.

  • Who are Aizon’s competitors?

    Innovaccer, MedeAnalytics, HealthVerity, Hindsait, and Prognos Health are some of the 62 competitors of Aizon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »